Adrenocortical Adenoma
Recent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes4
- Adenoma1
- Adrenocortical Adenoma1
- Cushing Syndrome1
- Frailty1
Leading journals1
- European journal of endocrinology1
Leading researchers8
- Achenbach SJ1
- Ambroziak U1
- Athimulam S1
- Atkinson EJ1
- Baikousi DA1
- Bancos I1
- Delivanis DA1
- Dogra P1
Affiliations (unnormalised)6
- Division of Clinical Trials and Biostatistics1
- Evangelismos Hospital1
- General Hospital Koprivnica1
- Mayo Clinic1
- Mayo Clinic College of Medicine1
- Medical College of Wisconsin1
Reference
Authoritative identity, definition & identifiers.
A benign neoplasm of the ADRENAL CORTEX. It is characterized by a well-defined nodular lesion, usually less than 2.5 cm. Most adrenocortical adenomas are nonfunctional. The functional ones are yellow and contain LIPIDS. Depending on the cell type or cortical zone involved, they may produce ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.